Active substance (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Technical information
Presentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
hRnzVRSQrq0rwXES
Listen
